| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0008 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.002 |